SCHEMBL31664536

SCHEMBL31664536

CNS(=O)(=O)c1scnc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 3/20 0.33
ALDH1A1 P00352 3/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PRF1 P14222 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
CA12 O43570 3/20 0.31
CA1 P00915 3/20 0.31
CA2 P00918 3/20 0.31
CA5A P35218 3/20 0.31
CA9 Q16790 3/20 0.31
CA5B Q9Y2D0 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL415794 0.85 KDM4E (0.36) KDM4EPKMLMNAALDH1A1KMT2A
SCHEMBL3129606 0.77 KDM4E (0.42) KDM4EPKMLMNAALDH1A1KMT2A
SCHEMBL21918985 0.77 KDM4E (0.42) KDM4EPKMLMNAALDH1A1KMT2A
SCHEMBL15142274 0.75 BCAT1 (0.44) KDM4EPKMSMN1; SMN2GAALMNA
SCHEMBL3989665 0.75 KDM4E (0.41) KDM4EPKMLMNAALDH1A1KMT2A
SCHEMBL2654567 0.75 KDM4E (0.45) KDM4EPKMLMNAALDH1A1KMT2A
SCHEMBL14612384 0.75 KDM4E (0.41) KDM4EPKMLMNAALDH1A1KMT2A
Hydrochloric Acid SCHEMBL27764055 0.73 KDM4E (0.44) KDM4EPKMLMNAALDH1A1KMT2A
SCHEMBL27458526 0.71 ALDH1A1 (0.40) KDM4EPKMSMN1; SMN2GAAALDH1A1
SCHEMBL15653253 0.67 KDM4E (0.39) KDM4EPKMVHL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236616-A1 IMMUNOMODULATING AZALIDES ZOETIS SERVICES LLC 2025-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250236616-A1 IMMUNOMODULATING AZALIDES IL2, MALT1, FCGRT KDM4E 646/4885PKM 4828/4885SMN1; SMN2 1802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.